Search

Kevin M. Picardat

Examiner (ID: 9381, Phone: (571)272-1841 , Office: P/2822 )

Most Active Art Unit
2822
Art Unit(s)
2813, 2825, 1104, 2899, 2822, 1763, 1732
Total Applications
2640
Issued Applications
2463
Pending Applications
47
Abandoned Applications
134

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7555330 [patent_doc_number] => 08067231 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-29 [patent_title] => 'Clostridial toxin activity assays' [patent_app_type] => utility [patent_app_number] => 11/908451 [patent_app_country] => US [patent_app_date] => 2006-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 17 [patent_no_of_words] => 95577 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/067/08067231.pdf [firstpage_image] =>[orig_patent_app_number] => 11908451 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/908451
Clostridial toxin activity assays Apr 3, 2006 Issued
Array ( [id] => 5062612 [patent_doc_number] => 20070224251 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => 'Hemostatic material' [patent_app_type] => utility [patent_app_number] => 11/385750 [patent_app_country] => US [patent_app_date] => 2006-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6884 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20070224251.pdf [firstpage_image] =>[orig_patent_app_number] => 11385750 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/385750
Hemostatic material Mar 21, 2006 Abandoned
Array ( [id] => 256216 [patent_doc_number] => 07575889 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-18 [patent_title] => 'Compound combinations for inhibiting cell division and methods for their identification and use' [patent_app_type] => utility [patent_app_number] => 11/376259 [patent_app_country] => US [patent_app_date] => 2006-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 26798 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/575/07575889.pdf [firstpage_image] =>[orig_patent_app_number] => 11376259 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/376259
Compound combinations for inhibiting cell division and methods for their identification and use Mar 13, 2006 Issued
Array ( [id] => 7800670 [patent_doc_number] => 08128940 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-06 [patent_title] => 'Modified clostridial toxins with enhanced targeting capabilities for endogenous clostridial toxin receptor systems' [patent_app_type] => utility [patent_app_number] => 11/908349 [patent_app_country] => US [patent_app_date] => 2006-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 198739 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/128/08128940.pdf [firstpage_image] =>[orig_patent_app_number] => 11908349 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/908349
Modified clostridial toxins with enhanced targeting capabilities for endogenous clostridial toxin receptor systems Mar 13, 2006 Issued
Array ( [id] => 5786414 [patent_doc_number] => 20060205648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Liquid, aqueous pharmaceutical compositions of factor VII polypeptides' [patent_app_type] => utility [patent_app_number] => 11/353335 [patent_app_country] => US [patent_app_date] => 2006-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16375 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0205/20060205648.pdf [firstpage_image] =>[orig_patent_app_number] => 11353335 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/353335
Liquid, aqueous pharmaceutical compositions of factor VII polypeptides Feb 13, 2006 Issued
Array ( [id] => 5278593 [patent_doc_number] => 20090130725 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'Gene Sms 14' [patent_app_type] => utility [patent_app_number] => 11/883639 [patent_app_country] => US [patent_app_date] => 2006-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17511 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20090130725.pdf [firstpage_image] =>[orig_patent_app_number] => 11883639 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/883639
Gene Sms 14 Feb 9, 2006 Abandoned
Array ( [id] => 5649671 [patent_doc_number] => 20060135406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Compositions and methods for treating pathologies that necessitate suppression of gastric acid secretion' [patent_app_type] => utility [patent_app_number] => 11/351001 [patent_app_country] => US [patent_app_date] => 2006-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15914 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20060135406.pdf [firstpage_image] =>[orig_patent_app_number] => 11351001 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/351001
Compositions and methods for treating pathologies that necessitate suppression of gastric acid secretion Feb 8, 2006 Abandoned
Array ( [id] => 4629156 [patent_doc_number] => 08008039 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-30 [patent_title] => 'Polydiacetylene-containing solid colorimetric and /or fluorescent detector, method for its preparation and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/795499 [patent_app_country] => US [patent_app_date] => 2006-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 5667 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/008/08008039.pdf [firstpage_image] =>[orig_patent_app_number] => 11795499 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/795499
Polydiacetylene-containing solid colorimetric and /or fluorescent detector, method for its preparation and uses thereof Jan 18, 2006 Issued
Array ( [id] => 5682982 [patent_doc_number] => 20060199252 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-07 [patent_title] => 'Genes encoding the synthetic pathway for the production of disorazole' [patent_app_type] => utility [patent_app_number] => 11/330623 [patent_app_country] => US [patent_app_date] => 2006-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 3217 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20060199252.pdf [firstpage_image] =>[orig_patent_app_number] => 11330623 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/330623
Genes encoding the synthetic pathway for the production of disorazole Jan 11, 2006 Abandoned
Array ( [id] => 5889802 [patent_doc_number] => 20060276392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Treatments employing neuronal exocytosis-inhibiting peptides' [patent_app_type] => utility [patent_app_number] => 11/327952 [patent_app_country] => US [patent_app_date] => 2006-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5816 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0276/20060276392.pdf [firstpage_image] =>[orig_patent_app_number] => 11327952 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/327952
Treatments employing neuronal exocytosis-inhibiting peptides Jan 8, 2006 Issued
Array ( [id] => 23316 [patent_doc_number] => 07794968 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-14 [patent_title] => 'Polydiacetylene-containing solid colorimetric and/or fluorescent detector, method for its preparation and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/328472 [patent_app_country] => US [patent_app_date] => 2006-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8278 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/794/07794968.pdf [firstpage_image] =>[orig_patent_app_number] => 11328472 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/328472
Polydiacetylene-containing solid colorimetric and/or fluorescent detector, method for its preparation and uses thereof Jan 8, 2006 Issued
Array ( [id] => 5598096 [patent_doc_number] => 20060162014 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Alternate morpheeins of allosteric proteins as a target for the development of bioactive molecules' [patent_app_type] => utility [patent_app_number] => 11/327762 [patent_app_country] => US [patent_app_date] => 2006-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 34341 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20060162014.pdf [firstpage_image] =>[orig_patent_app_number] => 11327762 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/327762
Alternate morpheeins of allosteric proteins as a target for the development of bioactive molecules Jan 5, 2006 Abandoned
Array ( [id] => 5865542 [patent_doc_number] => 20060099672 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Activatable recombinant neurotoxins' [patent_app_type] => utility [patent_app_number] => 11/326265 [patent_app_country] => US [patent_app_date] => 2006-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 15748 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20060099672.pdf [firstpage_image] =>[orig_patent_app_number] => 11326265 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/326265
Activatable recombinant neurotoxins Jan 4, 2006 Issued
Array ( [id] => 162881 [patent_doc_number] => 07671178 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-03-02 [patent_title] => 'Solubilization and reconstitution of silk using ionic liquids' [patent_app_type] => utility [patent_app_number] => 11/326678 [patent_app_country] => US [patent_app_date] => 2005-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 4337 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/671/07671178.pdf [firstpage_image] =>[orig_patent_app_number] => 11326678 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/326678
Solubilization and reconstitution of silk using ionic liquids Dec 28, 2005 Issued
Array ( [id] => 5678416 [patent_doc_number] => 20060183772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Anti-cancer compounds' [patent_app_type] => utility [patent_app_number] => 11/304269 [patent_app_country] => US [patent_app_date] => 2005-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7260 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20060183772.pdf [firstpage_image] =>[orig_patent_app_number] => 11304269 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/304269
Anti-cancer compounds Dec 13, 2005 Issued
Array ( [id] => 5690134 [patent_doc_number] => 20060288449 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Process for purifying target compounds from plant sources using ceramic filtration' [patent_app_type] => utility [patent_app_number] => 11/301469 [patent_app_country] => US [patent_app_date] => 2005-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8519 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20060288449.pdf [firstpage_image] =>[orig_patent_app_number] => 11301469 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/301469
Process for purifying target compounds from plant sources using ceramic filtration Dec 11, 2005 Abandoned
Array ( [id] => 5678528 [patent_doc_number] => 20060183884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Compounds and methods for modulating cell adhesion' [patent_app_type] => utility [patent_app_number] => 11/299289 [patent_app_country] => US [patent_app_date] => 2005-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 61 [patent_no_of_words] => 54774 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11299289 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/299289
Compounds and methods for modulating cell adhesion Dec 8, 2005 Abandoned
Array ( [id] => 517240 [patent_doc_number] => 07189541 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-13 [patent_title] => 'Botulinum toxin production method' [patent_app_type] => utility [patent_app_number] => 11/296015 [patent_app_country] => US [patent_app_date] => 2005-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10183 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/189/07189541.pdf [firstpage_image] =>[orig_patent_app_number] => 11296015 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/296015
Botulinum toxin production method Dec 6, 2005 Issued
Array ( [id] => 582413 [patent_doc_number] => 07445914 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-04 [patent_title] => 'Animal product free media and processes for obtaining a botulinum toxin' [patent_app_type] => utility [patent_app_number] => 11/296001 [patent_app_country] => US [patent_app_date] => 2005-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10179 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/445/07445914.pdf [firstpage_image] =>[orig_patent_app_number] => 11296001 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/296001
Animal product free media and processes for obtaining a botulinum toxin Dec 6, 2005 Issued
Array ( [id] => 177537 [patent_doc_number] => 07655244 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-02 [patent_title] => 'Targeted delivery of botulinum toxin for the treatment and prevention of trigeminal autonomic cephalgias, migraine and vascular conditions' [patent_app_type] => utility [patent_app_number] => 11/296079 [patent_app_country] => US [patent_app_date] => 2005-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5388 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/655/07655244.pdf [firstpage_image] =>[orig_patent_app_number] => 11296079 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/296079
Targeted delivery of botulinum toxin for the treatment and prevention of trigeminal autonomic cephalgias, migraine and vascular conditions Dec 6, 2005 Issued
Menu